Content |
Education
Natalya Kolerova graduated from the Moscow medical academy of I.M. Sechenov in "pharmacy" and Lomonosov Moscow State University in "sociology". Received MBA degree.
Biography
2008-2017
Natalya Kolerova joined Novartis company in 2008. In different years she was responsible for business division of specialized medicine, headed department of an output of medicines to the market.
In 2014 she was appointed the general manager of department of onkopreparat in Russia, Ukraine and the CIS countries.
2019: Appointment of Novartis as the head in Russia
At the beginning of August, 2019 it became known of Natalya Kolerova's appointment to a post of the president of Novartis in Russia instead of Vadim Vlasov who headed the company since 2010.
She will start responsibilities on September 1, 2019. Before heading the Russian division of Novartis, Kolerova was the general manager of department of oncological medicines in Russia, Ukraine and the CIS.
Kolerova will continue to fulfill duties of the CEO of Novartis of Pharm company on a post of the president of Novartis in Russia where together with oncological business the division Novartis of Pharm and issuer of the reproduced drugs and bioanalogues Sandoz enters.
On a post of the head of the Russian office Novartis Vadim Vlasov implemented investment and localization projects, in particular started production in St. Petersburg, constructed the relations with key partners and state agencies, says the message of the pharmaceutical giant.
Besides, Vlasov took active part in development of the pharmaceutical industry in Russia in general both as the chairman of the board of directors of Association of International Pharmaceutical Manufacturers (AIPM), and within activity of the company on the platform of the Advisory board on the foreign investments (KSII). Vadim Vlasov made the decision to leave the company, but did not state the reason.[1]